ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Shionogi Announces Positive Top-Line Results for Cefiderocol Pivotal cUTI Clinical Trial
January 13, 2017Shionogi & Co. has announced that cefiderocol (S-649266), a novel siderophore cephalosporin in late-stage development, met the FDA pre-specified primary endpoint for non-inferiority vs imipenem/cilastatin (IPM/CS) in patients with serious complicated urin
Pharma Sources Insight January 2025
